Label Changes for:
Aceon (perindopril erbumine) Tablets
Changes have been made to the CONTRAINDICATIONS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) –
- Do not co-administer aliskiren with Aceon in patients with diabetes